Buscador de Revistas

JAMA Oncology is the definitive journal for scientists, clinicians and trainees in the field of oncolgy worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenisis and recent treatment advances for our readers. JAMA oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

JMIR Cancer (JC) is a Pubmed- and ESCI-indexed, peer-reviewed journal with a focus on education, innovation and technology in cancer care, cancer survivorship and cancer research, as well as in participatory and patient-centred approaches. This journal also includes research on non-Internet approaches to improve cancer care and cancer research.

Manuscripts from key conferences dealing with cancer and closely related research fields, or a related group of papers on specific subjects of importance to cancer research, are considered for publication, with the understanding that they have not been published previously and are submitted exclusively to the Journal of the National Cancer Institute Monographs. All material submitted for consideration will be subject to review, when appropriate, by at least one outside reviewer and one member of the Editorial Board of the Journal of the National Cancer Institute. Opinions expressed by authors are not necessarily those of the publisher or the editors.

Japanese Journal of Clinical Oncology is a multidisciplinary journal for clinical oncologists which strives to publish high quality manuscripts addressing medical oncology, clinical trials, radiology, surgery, basic research, and palliative care. The journal aims to contribute to the world’s scientific community with special attention to the area of clinical oncology and the Asian region.JJCO publishes various articles types including:*Original Articles*Case Reports*Clinical Trial Notes*Cancer Genetics Reports*Epidemiology Notes*Technical Notes*Short Communications*Letters to the Editors*Solicited ReviewsThe journal also welcomes interim articles on the design and plan of phase studies before actual results are obtained. While clinical trials usually require a long time to accomplish a conclusive outcome, the journal believes reports of interim outcomes will be highly appreciated by its audience. .

Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.The journal welcomes submissions in the following areas and other related topics:Basic Tumor ImmunologyTumor antigens, innate and adaptive anti-tumor immune mechanisms, immune regulation, immune response, cancer and inflammation, preclinical models, chemotherapy and radiotherapy interactions with the anti-tumor immune responseClinical/Translational Cancer ImmunotherapyFirst-in-man clinical trials, phase II/III clinical studies, immune monitoring investigations, tumor microenvironment, host genetics and clinical outcomeImmunotherapy BiomarkersPredictive/prognostic biomarker studies, gene expression studies in cancer immunotherapy, serological immune biomarkers, multiparameter flow cytometry-defined immune biomarkers, high content immunohistological studiesReviews/EditorialsTriggering discussion on hot topics and innovative concepts

Journal for ImmunoTherapy of Cancer is the official journal of the Society for Immunotherapy of Cancer (SITC). The Society for Immunotherapy of Cancer (SITC) is a 501 (c)(3) non-profit society of medical professionals that was established in 1984 to exchange, encourage and promote information about the promise and breakthroughs of biological therapies, including immunotherapy, for patients with cancer. SITC is the world's leading member society of medical professionals dedicated to advancing cancer immunotherapy through its initiatives, educational sessions, and collaborative endeavors. The society has become THE forum for innovative discussions in the field.

The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject. The areas covered by the journal include:Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)Preclinical models of metastasisBone microenvironment in cancer (stem cell, bone cell and cancer interactions)Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)Bone imaging (clinical and animal, skeletal interventional radiology)Bone biomarkers (clinical and translational applications)Radiotherapy and radio-isotopesSkeletal complicationsBone pain (mechanisms and management)Orthopaedic cancer surgeryPrimary bone tumoursClinical guidelinesMultidisciplinary careKeywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour

This journal presents research that aims to improve current cancer education techniques and solve current problems that exist in educating patients, and strengthening existing programs. The Journal of Cancer Education serves as the ideal source to educate physicians, dentists, nurses, students, social workers as well as other allied health professionals, patients, and the general public in various aspects of cancer education techniques and current problems. International in scope, the journal features a varied editorial board made up of MDs and PhDs working in the field, who see the importance of disseminating information about improving cancer education worldwide.

Journal of Cancer Epidemiology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of cancer epidemiology.

The Journal of Cancer Policy is an international, open access journal which publishes research and reviews on global cancer policy. The journal encompasses all aspects of cancer policy and public health, including:* Health economics related to cancer* Drug development, including cost and regulatory issues* Drug and lifestyle mediated prevention of cancer* The management of cancer in low, middle and high income countries* Inequalities in cancer care* Priorities for cancer policy development* Cancer systems and organisation of care, research and education* Social determinants of cancer* Political economy of cancer* The role of patient advocacy groups in cancer policyThe Journal of Cancer Policy will consider original research, reviews, short communications and reports, and correspondence for publication.

The 'Journal of Cancer Research and Clinical Oncology' publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers and Rapid communications (given priority treatment by the Editors), also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses. The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.